Page 39 - உயிரி தொழில்நுட்பவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AUSTIN, TX & DURHAM, NC, Feb. 12, 2021 (GLOBE NEWSWIRE) Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will participate in Citi’s 2021 Virtual Immuno-Oncology Day Conference being held virtually February 17-18, 2021. Presentation DetailsConference: Citi 2021 Virtual Immuno-Oncology DayFormat: Group meeting with Andrew Baum and covering analyst Mohit BansalPresenters: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer and Andrew Neill, Shattuck’s Vice President of Finance and Corporate StrategyDate: February 17, 2021Time: 12:00 p.m. ESTWebcast Link: Available Here A live webcast will be available at the Events & Presentations section of the Company’s website. About Shattuck Labs, Inc.Shattuck is a clinical-stage biot

Shattuck labsBiologic medicineFusion proteinsAutoimmune diseaseImmuno oncologyBiotechnology companyஷாத்துக்க் ஆய்வகங்கள்உயிரியல் மருந்துஇணைவு ப்ரோடீந்ஸ்ஆட்டோ இம்யூன் நோய்இம்யூனோ புற்றுநோயியல்உயிரி தொழில்நுட்பவியல் நிறுவனம்